{"id":"https://openalex.org/W2113579149","doi":"https://doi.org/10.1016/j.amjhyper.2005.05.026","title":"Blockade of Sympathetic Nervous System Activity by Rilmenidine Increases Plasma Adiponectin Concentration in Patients With Essential Hypertension","display_name":"Blockade of Sympathetic Nervous System Activity by Rilmenidine Increases Plasma Adiponectin Concentration in Patients With Essential Hypertension","alternate_titles":[],"publication_year":2005,"publication_date":"2005-11-01","ids":{"openalex":"https://openalex.org/W2113579149","doi":"https://doi.org/10.1016/j.amjhyper.2005.05.026","mag":"2113579149","pmid":"https://pubmed.ncbi.nlm.nih.gov/16280284"},"language":"en","primary_location":{"id":"doi:10.1016/j.amjhyper.2005.05.026","doi":"https://doi.org/10.1016/j.amjhyper.2005.05.026","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.amjhyper.2005.05.026","pdf_url":null,"source":{"id":"https://openalex.org/S128891601","display_name":"American Journal of Hypertension","issn_l":"0895-7061","issn":["0895-7061","1941-7225"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Hypertension","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2113579149"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073181265","display_name":"\u0141ukasz Nowak","orcid":"https://orcid.org/0000-0003-4273-8196","observed_orcids":["https://orcid.org/0000-0003-4273-8196"]},"institutions":[{"id":"https://openalex.org/I166182418","display_name":"Medical University of Silesia","ror":"https://ror.org/005k7hp45","country_code":"PL","type":"education","lineage":["https://openalex.org/I166182418"]}],"countries":["PL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L NOWAK","raw_affiliation_strings":["Department of Nephrology, Endocrinology and Metabolic Diseases, Medical University of Silesia, Katowice, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nephrology, Endocrinology and Metabolic Diseases, Medical University of Silesia, Katowice, Poland","institution_ids":["https://openalex.org/I166182418"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069971154","display_name":"Marcin Adamczak","orcid":"https://orcid.org/0000-0002-0804-1718","observed_orcids":["https://orcid.org/0000-0002-0804-1718"]},"institutions":[{"id":"https://openalex.org/I166182418","display_name":"Medical University of Silesia","ror":"https://ror.org/005k7hp45","country_code":"PL","type":"education","lineage":["https://openalex.org/I166182418"]}],"countries":["PL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M ADAMCZAK","raw_affiliation_strings":["Department of Nephrology, Endocrinology and Metabolic Diseases, Medical University of Silesia, Katowice, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nephrology, Endocrinology and Metabolic Diseases, Medical University of Silesia, Katowice, Poland","institution_ids":["https://openalex.org/I166182418"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109783800","display_name":"A Wiecek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166182418","display_name":"Medical University of Silesia","ror":"https://ror.org/005k7hp45","country_code":"PL","type":"education","lineage":["https://openalex.org/I166182418"]}],"countries":["PL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A WIECEK","raw_affiliation_strings":["Department of Nephrology, Endocrinology and Metabolic Diseases, Medical University of Silesia, Katowice, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nephrology, Endocrinology and Metabolic Diseases, Medical University of Silesia, Katowice, Poland","institution_ids":["https://openalex.org/I166182418"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I166182418"],"apc_list":{"value":4814,"currency":"USD","value_usd":4814},"apc_paid":null,"fwci":3.2444,"has_fulltext":false,"cited_by_count":63,"citation_normalized_percentile":{"value":0.91715976,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":97},"biblio":{"volume":"18","issue":"11","first_page":"1470","last_page":"1475"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.6855000257492065,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.6855000257492065,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.2827000021934509,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12979","display_name":"Cardiovascular Disease and Adiposity","score":0.009100000374019146,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rilmenidine","display_name":"rilmenidine","score":0.9700000286102295},{"id":"https://openalex.org/keywords/adiponectin","display_name":"adiponectin","score":0.8510000109672546},{"id":"https://openalex.org/keywords/essential-hypertension","display_name":"essential hypertension","score":0.9919999837875366},{"id":"https://openalex.org/keywords/sympathetic-nerve-blockade","display_name":"sympathetic nerve block","score":0.9240000247955322},{"id":"https://openalex.org/keywords/insulin-sensitivity","display_name":"insulin sensitivity","score":0.9089999794960022},{"id":"https://openalex.org/keywords/body-fat-content","display_name":"body fat content","score":0.8569999933242798},{"id":"https://openalex.org/keywords/antihypertensive-therapy","display_name":"antihypertensive therapy","score":0.9200000166893005},{"id":"https://openalex.org/keywords/blood-pressure-reduction","display_name":"blood pressure reduction","score":0.7080000042915344},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.5320000052452087},{"id":"https://openalex.org/keywords/alpha-2-adrenergic-agonists","display_name":"alpha-2 adrenergic agonists","score":0.7549999952316284},{"id":"https://openalex.org/keywords/body-composition","display_name":"body composition","score":0.4399999976158142},{"id":"https://openalex.org/keywords/adipokines","display_name":"adipokines","score":0.4790000021457672}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9281395673751831},{"id":"https://openalex.org/C2780307058","wikidata":"https://www.wikidata.org/wiki/Q967973","display_name":"Rilmenidine","level":4,"score":0.9030101299285889},{"id":"https://openalex.org/C2776533406","wikidata":"https://www.wikidata.org/wiki/Q187215","display_name":"Sympathetic nervous system","level":3,"score":0.7803822755813599},{"id":"https://openalex.org/C2777097880","wikidata":"https://www.wikidata.org/wiki/Q988405","display_name":"Essential hypertension","level":3,"score":0.7063460946083069},{"id":"https://openalex.org/C2776782570","wikidata":"https://www.wikidata.org/wiki/Q357439","display_name":"Adiponectin","level":4,"score":0.6177011132240295},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.5765955448150635},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5558576583862305},{"id":"https://openalex.org/C123605464","wikidata":"https://www.wikidata.org/wiki/Q1659850","display_name":"Imidazoline receptor","level":2,"score":0.467928409576416},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.40394821763038635},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3918622136116028},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3447510302066803},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.2859131693840027},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.14105108380317688},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.1165253221988678},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.10273146629333496},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.07902511954307556}],"mesh":[{"descriptor_ui":"D000077769","descriptor_name":"Rilmenidine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010080","descriptor_name":"Oxazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013564","descriptor_name":"Sympathetic Nervous System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D013564","descriptor_name":"Sympathetic Nervous System","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052242","descriptor_name":"Adiponectin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.amjhyper.2005.05.026","doi":"https://doi.org/10.1016/j.amjhyper.2005.05.026","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.amjhyper.2005.05.026","pdf_url":null,"source":{"id":"https://openalex.org/S128891601","display_name":"American Journal of Hypertension","issn_l":"0895-7061","issn":["0895-7061","1941-7225"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Hypertension","raw_type":"journal-article"},{"id":"pmid:16280284","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16280284","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of hypertension","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":53,"referenced_works":["https://openalex.org/W1562891630","https://openalex.org/W1965362290","https://openalex.org/W1965973886","https://openalex.org/W1981261500","https://openalex.org/W1997978122","https://openalex.org/W1998111567","https://openalex.org/W2001266437","https://openalex.org/W2001727439","https://openalex.org/W2004033224","https://openalex.org/W2013439787","https://openalex.org/W2024013377","https://openalex.org/W2036417798","https://openalex.org/W2037580369","https://openalex.org/W2042257745","https://openalex.org/W2043143883","https://openalex.org/W2045254223","https://openalex.org/W2046158926","https://openalex.org/W2049281770","https://openalex.org/W2051625732","https://openalex.org/W2055378578","https://openalex.org/W2057051427","https://openalex.org/W2065845925","https://openalex.org/W2068768095","https://openalex.org/W2069014013","https://openalex.org/W2075142418","https://openalex.org/W2080325754","https://openalex.org/W2095726149","https://openalex.org/W2104041304","https://openalex.org/W2105912552","https://openalex.org/W2106875810","https://openalex.org/W2107865201","https://openalex.org/W2108931588","https://openalex.org/W2111116814","https://openalex.org/W2113273743","https://openalex.org/W2120977310","https://openalex.org/W2124376410","https://openalex.org/W2131541226","https://openalex.org/W2132681327","https://openalex.org/W2133545915","https://openalex.org/W2138750223","https://openalex.org/W2139801418","https://openalex.org/W2141608973","https://openalex.org/W2145524929","https://openalex.org/W2146266563","https://openalex.org/W2150532258","https://openalex.org/W2155252568","https://openalex.org/W2158965622","https://openalex.org/W2162732750","https://openalex.org/W2163678936","https://openalex.org/W2166370133","https://openalex.org/W2293059847","https://openalex.org/W2463215628","https://openalex.org/W4256592710"],"related_works":["https://openalex.org/W1979987305","https://openalex.org/W2355988917","https://openalex.org/W2113273743","https://openalex.org/W2348918265","https://openalex.org/W2068768095","https://openalex.org/W4379932004","https://openalex.org/W2352672422","https://openalex.org/W2051143826","https://openalex.org/W2086762757","https://openalex.org/W2391785276"],"abstract_inverted_index":{"BACKGROUND:":[0],"Adiponectin":[1],"is":[2,27],"an":[3,265],"adipose":[4],"tissue-specific":[5],"protein":[6],"with":[7,14,61,69,76,139,153,236,261,264,284],"antiatherogenic":[8],"and":[9,113,123,132,169,187,199,204,213,218,225,278],"insulin-sensitizing":[10],"properties.":[11],"In":[12,73],"patients":[13,68,75,283],"essential":[15,70,77,285],"hypertension":[16,78,92],"plasma":[17,31,64,97,242,268],"adiponectin":[18,32,65,98,243,269],"levels":[19],"are":[20],"lower":[21],"than":[22],"in":[23,37,43,67,156,241,282],"healthy":[24],"subjects.":[25],"It":[26],"hypothetized":[28],"that":[29],"low":[30],"concentration":[33,66,99,244,270],"may":[34],"be":[35],"involved":[36],"the":[38,48,53,118],"pathogenesis":[39],"of":[40,47,55,58,91,110,136,151,160,180,234,267,275],"vascular":[41],"complications":[42],"hypertension.":[44,71,286],"The":[45,148],"aim":[46],"study":[49],"was":[50,256],"to":[51,144,249],"evaluate":[52],"effect":[54],"6":[56,134,149,232],"months":[57,135,150,233],"antihypertensive":[59,137],"therapy":[60,260],"rilmenidine":[62,140,154,237,262],"on":[63],"METHODS:":[72],"20":[74],"(mean":[79],"age":[80],"39":[81],"+/-":[82,94,185,189,197,201,211,215,223,227,247,251],"14":[83],"years;":[84],"11":[85],"F,":[86],"9":[87,95],"M;":[88],"mean":[89,170],"duration":[90],"8":[93],"years)":[96],"(ELISA;":[100],"B-Bridge":[101],"International,":[102],"San":[103],"Jose,":[104],"CA),":[105],"insulin":[106,115,205,220,276],"sensitivity":[107,206,277],"(metabolic":[108],"clearance":[109],"glucose-M":[111],"value":[112,209],"M/plasma":[114,219],"ratio)":[116],"by":[117],"euglycemic-hyperinsulinemic":[119],"glucose":[120],"clamp":[121],"technique,":[122],"body":[124,181,193,279],"fat":[125,194,280],"content":[126,195,281],"(DEXA)":[127],"were":[128],"estimated":[129],"twice,":[130],"before":[131],"after":[133,231],"monotherapy":[138],"(daily":[141],"dose":[142],"1":[143],"2":[145],"mg).":[146],"RESULTS:":[147],"treatment":[152,235],"resulted":[155],"a":[157,238],"significant":[158,178,239,273],"decrease":[159],"systolic":[161],"(P":[162,166,174],"=":[163,167,175,254],".007),":[164],"diastolic":[165],".002),":[168,176],"arterial":[171],"blood":[172],"pressure":[173],"no":[177],"change":[179],"mass":[182],"index":[183],"(27.7":[184],"4.7":[186],"27.6":[188],"4.4":[190],"kg/m(2)),":[191],"total":[192],"(25.4":[196],"7.3":[198],"24.9":[200],"6.8":[202],"kg),":[203],"parameters":[207],"(M":[208],"6.0":[210],"2.5":[212],"5.8":[214],"4.3":[216,228],"mg/kg/min":[217],"ratio":[221],"7.4":[222],"5.0":[224],"6.9":[226],"mg/kg/min/mU/L).":[229],"However":[230],"increase":[240,266],"(from":[245],"12.5":[246],"6.1":[248],"16.9":[250],"11.1;":[252],"P":[253],".0002)":[255],"observed.":[257],"CONCLUSIONS:":[258],"Antihypertensive":[259],"correlates":[263],"without":[271],"any":[272],"changes":[274]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2113579149","counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
